FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Fed cuts rates, but two officials dissent, as policymakers debate next steps amid data uncertainty and a government shutdown.
Trump and Xi meet in Busan, signaling progress in US-China trade talks and a mutual desire to stabilize their complex economic relationship.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Fed cuts rates, but two officials dissent, as policymakers debate next steps amid data uncertainty and a government shutdown.
Trump and Xi meet in Busan, signaling progress in US-China trade talks and a mutual desire to stabilize their complex economic relationship.
